"Influenza, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Descriptor ID |
D007251
|
| MeSH Number(s) |
C02.782.620.365 C08.730.310
|
| Concept/Terms |
Influenza, Human- Influenza, Human
- Human Influenzas
- Influenzas, Human
- Influenza
- Influenzas
- Human Flu
- Flu, Human
- Human Influenza
- Influenza in Humans
- Influenza in Human
- Grippe
|
Below are MeSH descriptors whose meaning is more general than "Influenza, Human".
Below are MeSH descriptors whose meaning is more specific than "Influenza, Human".
This graph shows the total number of publications written about "Influenza, Human" by people in this website by year, and whether "Influenza, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 5 | 0 | 5 |
| 2006 | 4 | 2 | 6 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 6 | 0 | 6 |
| 2010 | 3 | 1 | 4 |
| 2011 | 17 | 1 | 18 |
| 2012 | 11 | 2 | 13 |
| 2013 | 14 | 1 | 15 |
| 2014 | 9 | 2 | 11 |
| 2015 | 4 | 1 | 5 |
| 2016 | 3 | 2 | 5 |
| 2017 | 13 | 1 | 14 |
| 2018 | 2 | 1 | 3 |
| 2019 | 4 | 0 | 4 |
| 2020 | 10 | 0 | 10 |
| 2021 | 4 | 0 | 4 |
| 2022 | 8 | 0 | 8 |
| 2023 | 10 | 1 | 11 |
| 2024 | 15 | 0 | 15 |
| 2025 | 10 | 0 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza, Human" by people in Profiles.
-
Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017-18 through 2022-23 influenza seasons. Vaccine. 2025 Oct 03; 64:127667.
-
Cardiovascular-Focused Messaging to Improve Influenza Vaccination Rates. NEJM Evid. 2025 Oct; 4(10):EVIDoa2500208.
-
Effectiveness of Cell Culture-Based Influenza Vaccine, 2023-2024. J Pediatric Infect Dis Soc. 2025 Aug 27; 14(8).
-
Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age. Vaccine. 2025 Aug 30; 62:127483.
-
Influenza Vaccination During Pregnancy and Infant Influenza in the First 6 Months of Life. Obstet Gynecol. 2025 Jun 26; 146(2):e36-e42.
-
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. Vaccine. 2025 Aug 13; 61:127361.
-
Electronically delivered, cardiovascular-focused messaging to improve influenza vaccination: Rationale, design, and baseline characteristics of the Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement (KP-VACCINATE) Megatrial. Am Heart J. 2025 Dec; 290:129-139.
-
Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021-2023. Clin Infect Dis. 2025 Jun 04; 80(5):1032-1044.
-
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
-
Estimating the generation time for influenza transmission using household data in the United States. Epidemics. 2025 Mar; 50:100815.